The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Prognostic index for chronic and smoldering types adult T-cell leukemia/lymphoma.
 
Hiroo Katsuya
Research Funding - Chugai Pharma (Inst); Nippon Kayaku (Inst); Ono Pharmaceutical (Inst); Sanofi (Inst); Taiho Pharmaceutical (Inst); Yakult Pharmaceutical (Inst)
 
Mototsugu Shimokawa
No Relationships to Disclose
 
Kenji Ishitsuka
No Relationships to Disclose
 
Kazuhiro Kawai
No Relationships to Disclose
 
Masahiro Amano
No Relationships to Disclose
 
Atae Utsunomiya
Honoraria - Bristol-Myers Squibb Japan; Chugai Pharma; Kyowa Hakko Kirin
 
Ryosuke Hino
No Relationships to Disclose
 
Shuichi Hanada
No Relationships to Disclose
 
Tatsuro Jo
No Relationships to Disclose
 
Kunihiro Tsukasaki
Consulting or Advisory Role - HUYA Bioscience International; SymBio Pharmaceuticals; Takeda
Research Funding - Celgene; Chugai Pharma; Eisai; Nippon Shinyaku; Novartis; Pfizer; Takeda
 
Yukiyoshi Moriuchi
No Relationships to Disclose
 
Eisaburo Sueoka
No Relationships to Disclose
 
Shinichiro Yoshida
No Relationships to Disclose
 
Hitoshi Suzushima
No Relationships to Disclose
 
Masaharu Miyahara
No Relationships to Disclose
 
Kiyoshi Yamashita
No Relationships to Disclose
 
Tetsuya Eto
No Relationships to Disclose
 
Takeharu Yamanaka
No Relationships to Disclose
 
Junji Suzumiya
Consulting or Advisory Role - Kyowa Hakko Kirin; Zenyaku Kogyo
Speakers' Bureau - Chugai Pharma; Kyowa Hakko Kirin
Research Funding - Chugai Pharma
Patents, Royalties, Other Intellectual Property - Cellgentech
 
Kazuo Tamura
Honoraria - Asahi Kasei; Kyowa Hakko Kirin
Research Funding - Astellas Pharma; Dainippon Sumitomo Pharma; Eisai; Shionogi